logo
HSBC's Ramachandran: Tariff Shifts a Completely New Playbook

HSBC's Ramachandran: Tariff Shifts a Completely New Playbook

Yahoo24-05-2025

HSBC's Global Head of Trade Solutions, Vivek Ramachandran discusses how tariffs have changed global trade. "No one expects the world to go back", he says, as business reshape and change their models and supply chains. Ramachandran speaks exclusively on "The Opening Trade" on Bloomberg Television.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

China's Copper Boom Under Threat as Miners Test Bargaining Power
China's Copper Boom Under Threat as Miners Test Bargaining Power

Bloomberg

timean hour ago

  • Bloomberg

China's Copper Boom Under Threat as Miners Test Bargaining Power

The unrelenting expansion of Chinese copper processing capacity over the past few years has now become a global headache, as smelters scramble to secure the ore they need to produce the vital industrial metal. Output in the world's top producer of the refined metal has ballooned to a record this year, even in the face of trade tensions wars that are clouding the outlook for demand. The resulting competition has handed bargaining power to some of the world's largest miners.

What to Expect From US, China Trade Talks Monday?
What to Expect From US, China Trade Talks Monday?

Yahoo

time2 hours ago

  • Yahoo

What to Expect From US, China Trade Talks Monday?

Mary Lovely, Senior Fellow at the Peterson Institute for International Economics, shares her thoughts on what to expect Monday as US and Chinese negotiators will resume trade talks in London. She also talks about the Trump tariffs and the impact the tariffs may have on the labor market if trade talks between the US and China do not go well. Mary Lovely speaks with Kailey Leinz and Joe Mathieu on the late edition of Bloomberg's "Balance of Power."

Eli Lilly's obesity drug sales rise in India, Bloomberg reports
Eli Lilly's obesity drug sales rise in India, Bloomberg reports

Business Insider

time2 hours ago

  • Business Insider

Eli Lilly's obesity drug sales rise in India, Bloomberg reports

Eli Lilly (LLY) increased its sale of Mounjaro, its weight-loss and diabetes drug, by 60% in India in May from April, Satviki Sanjay of Bloomberg reports. The company sold $1.5M worth of injections last month, Bloomberg said, citing market analysis firm Pharmarack Technologies. 'The patient number may have actually doubled' in May from April Pharmarack Vice President Sheetal Sapale told Bloomberg News. The demand is rising gradually and is expected to continue. Confident Investing Starts Here:

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store